CD8A and metastatic melanoma: Still, the presence alone of TRMs does not always guarantee metastatic control: in a vaginal metastatic melanoma patient, CD8+CD103+ TRM cells clustered at the margins of distant metastases and expanded following anti-PD1 therapy but were insufficient to clear the tumors due to tumor MHC-I loss [42].